MeSH Review:
Radiotherapy
Poortmans,
Kluin-Nelemans,
Haaxma-Reiche,
Van't Veer,
Hansen,
Soubeyran,
Taphoorn,
Thomas,
Van den Bent,
Fickers,
Van Imhoff,
Rozewicz,
Teodorovic,
van Glabbeke,
Ponten,
Lindman,
Bostrom,
Berne,
Bergh,
Hortobagyi,
Buzdar,
Theriault,
Valero,
Frye,
Booser,
Holmes,
Giralt,
Khouri,
Andersson,
Gajewski,
Rondon,
Smith,
Singletary,
Ames,
Sneige,
Strom,
McNeese,
Deisseroth,
Champlin,
Pearcey,
Brundage,
Drouin,
Jeffrey,
Johnston,
Lukka,
MacLean,
Souhami,
Stuart,
Tu,
Bentzen,
Atasoy,
Daley,
Dische,
Richman,
Saunders,
Trott,
Wilson,
Serkies,
Jassem,
Arcasoy,
Amin,
Chou,
Haroon,
Varia,
Raleigh,
Pollack,
Grignon,
Heydon,
Hammond,
Lawton,
Mesic,
Fu,
Porter,
Abrams,
Shipley,
Keller,
Adak,
Wagner,
Herskovic,
Komaki,
Brooks,
Perry,
Livingston,
Johnson,
Yao,
Smith,
Graham,
Hoffman,
Tan,
Funk,
Graham,
Chang,
Dornfeld,
Menda,
Buatti,
- Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. Schaake-Koning, C., van den Bogaert, W., Dalesio, O., Festen, J., Hoogenhout, J., van Houtte, P., Kirkpatrick, A., Koolen, M., Maat, B., Nijs, A. N. Engl. J. Med. (1992)
- Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Bergh, J., Norberg, T., Sjögren, S., Lindgren, A., Holmberg, L. Nat. Med. (1995)
- Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy. Samuels, M.L., Johnson, D.E., Holoye, P.Y., Lanzotti, V.J. JAMA (1976)
- Immune response induced in small-cell lung cancer by maintenance therapy with interferon gamma. Pujol, J.L., Gibney, D.J., Su, J.Q., Maksymiuk, A.W., Jett, J.R. J. Natl. Cancer Inst. (1993)
- Metronidazole: effect on radiosensitivity of tumor and normal tissues in mice. Stone, H.B., Withers, H.R. J. Natl. Cancer Inst. (1975)
- The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations. Ohebshalom, M., Parker, M., Guhring, P., Mulhall, J.P. J. Urol. (2005)
- Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Serkies, K., Jassem, J. Int. J. Radiat. Oncol. Biol. Phys. (2004)
- The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Yao, M., Smith, R.B., Graham, M.M., Hoffman, H.T., Tan, H., Funk, G.F., Graham, S.M., Chang, K., Dornfeld, K.J., Menda, Y., Buatti, J.M. Int. J. Radiat. Oncol. Biol. Phys. (2005)
- Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives. Tzanopoulou, S., Pirmettis, I.C., Patsis, G., Raptopoulou, C., Terzis, A., Papadopoulos, M., Pelecanou, M. Inorganic chemistry. (2006)
- Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myeloma. Goldschmidt, H., Hegenbart, U., Moos, M., Eugenhart, R., Wannenmacher, M., Haas, R., Hunstein, W. Stem Cells (1995)
- Use of antioxidants during chemotherapy and radiotherapy should be avoided. D'Andrea, G.M. CA: a cancer journal for clinicians. (2005)
- Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. Macdonald, J.S., Smalley, S.R., Benedetti, J., Hundahl, S.A., Estes, N.C., Stemmermann, G.N., Haller, D.G., Ajani, J.A., Gunderson, L.L., Jessup, J.M., Martenson, J.A. N. Engl. J. Med. (2001)
- A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. Keller, S.M., Adak, S., Wagner, H., Herskovic, A., Komaki, R., Brooks, B.J., Perry, M.C., Livingston, R.B., Johnson, D.H. N. Engl. J. Med. (2000)
- Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. Brizel, D.M., Albers, M.E., Fisher, S.R., Scher, R.L., Richtsmeier, W.J., Hars, V., George, S.L., Huang, A.T., Prosnitz, L.R. N. Engl. J. Med. (1998)
- Risk of leukemia after chemotherapy and radiation treatment for breast cancer. Curtis, R.E., Boice, J.D., Stovall, M., Bernstein, L., Greenberg, R.S., Flannery, J.T., Schwartz, A.G., Weyer, P., Moloney, W.C., Hoover, R.N. N. Engl. J. Med. (1992)
- Control of local tumor growth with combined fractionated radiotherapeutic and chemotherapeutic regimens. Poulakos, L., Schenken, L.L., Hagemann, R.F., Burholt, D.R., Lesher, S. J. Natl. Cancer Inst. (1975)
- Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. Travis, L.B., Curtis, R.E., Glimelius, B., Holowaty, E.J., Van Leeuwen, F.E., Lynch, C.F., Hagenbeek, A., Stovall, M., Banks, P.M., Adami, J. J. Natl. Cancer Inst. (1995)
- Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. Andersson, M., Storm, H.H., Mouridsen, H.T. J. Natl. Cancer Inst. (1991)
- Preferential cytotoxicity of 5-thio-D-glucose against hypoxic tumor cells. Song, C.W., Clement, J.J., Levitt, S.H. J. Natl. Cancer Inst. (1976)
- Effects of combined radiotherapy and immunotherapy with the use of pyran copolymer on murine fibrosarcoma. Collins, A.L., Song, C.W. J. Natl. Cancer Inst. (1978)
- Induction of p53 expression in skin by radiotherapy and UV radiation: a randomized study. Ponten, F., Lindman, H., Bostrom, A., Berne, B., Bergh, J. J. Natl. Cancer Inst. (2001)
- Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. Herr, I., Wilhelm, D., Böhler, T., Angel, P., Debatin, K.M. EMBO J. (1997)
- STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Khodarev, N.N., Beckett, M., Labay, E., Darga, T., Roizman, B., Weichselbaum, R.R. Proc. Natl. Acad. Sci. U.S.A. (2004)
- Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. Raybaud-Diogène, H., Fortin, A., Morency, R., Roy, J., Monteil, R.A., Têtu, B. J. Clin. Oncol. (1997)
- Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. Pollack, A., Grignon, D.J., Heydon, K.H., Hammond, E.H., Lawton, C.A., Mesic, J.B., Fu, K.K., Porter, A.T., Abrams, R.A., Shipley, W.U. J. Clin. Oncol. (2003)
- Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. Hortobagyi, G.N., Buzdar, A.U., Theriault, R.L., Valero, V., Frye, D., Booser, D.J., Holmes, F.A., Giralt, S., Khouri, I., Andersson, B., Gajewski, J.L., Rondon, G., Smith, T.L., Singletary, S.E., Ames, F.C., Sneige, N., Strom, E.A., McNeese, M.D., Deisseroth, A.B., Champlin, R.E. J. Natl. Cancer Inst. (2000)
- Combined-modality oncotherapy with cyclophosphamide (NSC-26271) and radiotherapy: control of murine mastocytoma. Schenken, L.L., Hagemann, R.F., Burholt, D.R., Lesher, S. J. Natl. Cancer Inst. (1976)
- Adriamycin and enhanced radiation reaction in normal esophagus and skin. Greco, F.A., Brereton, H.D., Kent, H., Zimbler, H., Merrill, J., Johnson, R.E. Ann. Intern. Med. (1976)
- Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. Pearcey, R., Brundage, M., Drouin, P., Jeffrey, J., Johnston, D., Lukka, H., MacLean, G., Souhami, L., Stuart, G., Tu, D. J. Clin. Oncol. (2002)
- High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Poortmans, P.M., Kluin-Nelemans, H.C., Haaxma-Reiche, H., Van't Veer, M., Hansen, M., Soubeyran, P., Taphoorn, M., Thomas, J., Van den Bent, M., Fickers, M., Van Imhoff, G., Rozewicz, C., Teodorovic, I., van Glabbeke, M. J. Clin. Oncol. (2003)
- Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. Keys, H.M., Bundy, B.N., Stehman, F.B., Muderspach, L.I., Chafe, W.E., Suggs, C.L., Walker, J.L., Gersell, D. N. Engl. J. Med. (1999)
- Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. Walker, M.D., Green, S.B., Byar, D.P., Alexander, E., Batzdorf, U., Brooks, W.H., Hunt, W.E., MacCarty, C.S., Mahaley, M.S., Mealey, J., Owens, G., Ransohoff, J., Robertson, J.T., Shapiro, W.R., Smith, K.R., Wilson, C.B., Strike, T.A. N. Engl. J. Med. (1980)
- Leukemia following Hodgkin's disease. Kaldor, J.M., Day, N.E., Clarke, E.A., Van Leeuwen, F.E., Henry-Amar, M., Fiorentino, M.V., Bell, J., Pedersen, D., Band, P., Assouline, D. N. Engl. J. Med. (1990)
- Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. Hong, W.K., Lippman, S.M., Itri, L.M., Karp, D.D., Lee, J.S., Byers, R.M., Schantz, S.P., Kramer, A.M., Lotan, R., Peters, L.J. N. Engl. J. Med. (1990)
- Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. Bentzen, S.M., Atasoy, B.M., Daley, F.M., Dische, S., Richman, P.I., Saunders, M.I., Trott, K.R., Wilson, G.D. J. Clin. Oncol. (2005)
- Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. Chan, L.W., Moses, M.A., Goley, E., Sproull, M., Muanza, T., Coleman, C.N., Figg, W.D., Albert, P.S., Ménard, C., Camphausen, K. J. Clin. Oncol. (2004)
- Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Kishi, K., Petersen, S., Petersen, C., Hunter, N., Mason, K., Masferrer, J.L., Tofilon, P.J., Milas, L. Cancer Res. (2000)
- Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia. Arcasoy, M.O., Amin, K., Chou, S.C., Haroon, Z.A., Varia, M., Raleigh, J.A. Clin. Cancer Res. (2005)
- APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Sak, S.C., Harnden, P., Johnston, C.F., Paul, A.B., Kiltie, A.E. Clin. Cancer Res. (2005)
- Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group. Rutqvist, L.E., Mattsson, A. J. Natl. Cancer Inst. (1993)
- Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. Lefebvre, J.L., Chevalier, D., Luboinski, B., Kirkpatrick, A., Collette, L., Sahmoud, T. J. Natl. Cancer Inst. (1996)
- Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Overgaard, M., Jensen, M.B., Overgaard, J., Hansen, P.S., Rose, C., Andersson, M., Kamby, C., Kjaer, M., Gadeberg, C.C., Rasmussen, B.B., Blichert-Toft, M., Mouridsen, H.T. Lancet (1999)
- Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group study. Sullivan, M.P., Chen, T., Dyment, P.G., Hvizdala, E., Steuber, C.P. Blood (1982)